Detalhe da pesquisa
1.
Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling.
Blood
; 122(19): 3322-30, 2013 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24089327
2.
Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to AML Blasts Than Cytokine-Induced Normal Human Hematopoietic CD34+ Cells.
Gene Expr
; 16(4): 169-175, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637397
3.
The complexity of identifying cancer stem cell biomarkers.
Cancer Invest
; 31(6): 404-11, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23758188
4.
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy.
Cancers (Basel)
; 14(21)2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358672
5.
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
Cancers (Basel)
; 14(19)2022 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230624
6.
Can hsp90alpha-targeted siRNA combined with TMZ be a future therapy for glioma?
Cancer Invest
; 28(6): 608-14, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20210521
7.
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Leukemia
; 34(6): 1613-1625, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31896780
8.
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
Leukemia
; 34(2): 427-440, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31611628
9.
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Leukemia
; 34(7): 1975, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005922
10.
Exploring Stem Cell Heterogeneity in Chronic Myeloid Leukemia.
Trends Cancer
; 4(3): 167-169, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506666
11.
A novel therapeutic strategy for the treatment of glioma, combining chemical and molecular targeting of hsp90a.
Cancers (Basel)
; 3(4): 4228-44, 2011 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24213135